Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2003
09/18/2003US20030176378 Vaccines and gene therapy compositions and methods of making and using the same
09/18/2003US20030176352 Peptides and related compounds having thrombopoietic activity
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176340 For therapy of renal failure
09/18/2003US20030176338 Novel serine-threonine kinase
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176330 55562 and 21617, novel human proteins and methods of use thereof
09/18/2003US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha
09/18/2003US20030175977 Bacteria reproduced in Deinococcus; endogenous plasmids
09/18/2003US20030175976 Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them
09/18/2003US20030175974 Human gene therapy
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175964 Wound healing agents; cell differentiation
09/18/2003US20030175963 Platform for the differentiation of cells
09/18/2003US20030175961 Immortal micorvascular endothelial cells and uses thereof
09/18/2003US20030175960 Isolation, cloning of genes; anticancer agents, autoimmune disease; genetic engineered cells immobilized with hyaluronic acid
09/18/2003US20030175959 Genetically engineered skin cell types and toxicity assays
09/18/2003US20030175958 Methods for using bag expression as a cell differentiation agent and marker
09/18/2003US20030175957 Pre-adipose cell lines
09/18/2003US20030175956 Feeder-free culture method for embryonic stem cell
09/18/2003US20030175955 Immortalization stem cell; animal growth regulators; formingantibodies
09/18/2003US20030175954 Human embryoid body-derived cells
09/18/2003US20030175953 Immortalized vascular adventital cell line
09/18/2003US20030175951 Culture product containing polyacid;such as citric acid
09/18/2003US20030175937 Cathepsin O2 protease
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175931 DNA molecules coding for debranching enzymes derived from plants
09/18/2003US20030175929 Recombinant human creatine kinase heterodimer with solution-stability
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175917 Method of sorting cells
09/18/2003US20030175913 Anticancer agents; adding stimulants to plant cell culture
09/18/2003US20030175909 Novel thermostable galactose isomerase and tagatose production thereby
09/18/2003US20030175902 Methods for producing hyaluronan in a recombinant host cell
09/18/2003US20030175901 Genetic engineering; polyketides
09/18/2003US20030175900 Compositions and methods for the treatment of tumor
09/18/2003US20030175895 Chemokine
09/18/2003US20030175894 Chemokine alpha-6
09/18/2003US20030175888 Discrete acyltransferases associated with type I polyketide synthases and methods of use
09/18/2003US20030175887 Saturation mutagenesis in directed evolution
09/18/2003US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
09/18/2003US20030175882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment
09/18/2003US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes
09/18/2003US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/18/2003US20030175859 Fluorescent proteins
09/18/2003US20030175855 Human sdf-5 protein and compositions
09/18/2003US20030175850 Devices and methods for isolating target cells
09/18/2003US20030175847 Method of preparing heart muscle cells and method of searching for remedy for heart diseases
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175818 Devices and methods for isolating and recovering target cells
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175801 Treating cancer via increase in expression of interferons and colony stimulating factors with concomitant decrease in transforming growth factor, prostaglandin and vascular endothelial growth factors expression in cells; immunoassays
09/18/2003US20030175790 High throughput screening for detecting modulators of molecular interaction and cellular processes
09/18/2003US20030175766 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175739 Nucleic acids, proteins, and antibodies
09/18/2003US20030175738 Rna polymerase mutants with increased thermostability
09/18/2003US20030175692 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
09/18/2003US20030175683 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses
09/18/2003US20030175410 Grafting to three-dimensional structure; grafting to cells
09/18/2003US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175297 Cancer vaccines
09/18/2003US20030175296 Chimaeric hepadnavirus core antigen proteins
09/18/2003US20030175289 TIE ligands
09/18/2003US20030175276 Monoclonal antibodies used as antagonists vascular endothelial growth factors (VEGF); angiogenesis inhibitors; antitumor agents
09/18/2003US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
09/18/2003US20030175273 Monoclonal antibodies which preferentially bind to chemokine receptors, used for immunotherapy, as antiinflammatory, aniticarcinogenic agents and for prophylaxis of respiratory system disorders or antiallergens
09/18/2003US20030175272 Re-activated T-cells for adoptive immunotherapy
09/18/2003US20030175257 Cartilage regeneration using chondrocyte and TGF-beta
09/18/2003US20030175256 Allografts comprising undifferentiated fetal skin cells integrated within collagen matrix
09/18/2003US20030175255 Which express intercellular adhesion molecule antigen and not major histocompatability complex; for treatment of genetic disorders
09/18/2003US20030175254 Separating population based on density and size of cells via elution then cetrifugation; for secretion of neuroendocrine hormones
09/18/2003US20030175252 Therapeutic compounds for ovarian cancer
09/18/2003US20030175250 Isolated peptides which bind to HLA molecules and uses thereof
09/18/2003US20030175249 For labeling/activating antigen presenting cells; chaperone proteins
09/18/2003US20030175247 For activating lymphocytes (CD-8 antigens) in response to metastatic cancer; tumor associated antigens; major histocompatibility complex; cryopreservation; prostate specific antigen
09/18/2003US20030175245 Replication deficient adenoviral TNF vector
09/18/2003US20030175243 Blocking receptor binding; gene therapy; gastrin releasing peptide
09/18/2003US20030175242 Cell therapy system
09/18/2003DE20121877U1 Module for suppressing leukocyte activity, useful e.g. in association with heart-lung machines, comprises a carrier linked to a ligand specific for the leukocyte receptor
09/18/2003CA2813780A1 Genetic products differentially expressed in tumors and use thereof
09/18/2003CA2479056A1 Protein sustaining undifferentiated stem cells as such
09/18/2003CA2479021A1 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
09/18/2003CA2478904A1 Modified gene-silencing rna and uses thereof
1 ... 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 ... 1827